Accepted for Publication: April 13, 2020.
Published: May 7, 2020. doi:10.1001/jamanetworkopen.2020.8292
Correction: This article was corrected on June 1, 2020, to fix an omission in the Methods.
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Li D et al. JAMA Network Open.
Corresponding Authors: Weiguo Zhao, MD, Department of Respiratory Medicine, The Eighth Medical Center of Chinese People’s Liberation Army General Hospital, 17th Heishanhu Road, Beijing, 100093, China (firstname.lastname@example.org); Shixi Zhang, MD, Shangqiu Municipal Hospital, Shangqiu, No. 1 Yingbin Road, Shangqiu City, Henan Province, China, 476100, China (Shixizhang1977@163.com).
Author Contributions: Drs Zhao and Zhang had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Li, Jin, and Bao contributed equally to this work.
Concept and design: Li, Jin, Zhao, Zhang.
Acquisition, analysis, or interpretation of data: Li, Jin, Bao.
Drafting of the manuscript: Li, Jin.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Li, Jin, Bao.
Obtained funding: Li, Jin.
Administrative, technical, or material support: Li, Zhao, Zhang.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was partially supported by grant KF2018-06 from the Open Project Program of the State Key Laboratory of Kidney Diseases in People’s Liberation Army General Hospital.
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
W , Ni
Z-y , Hu
et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med
. Published online February 28, 2020. doi:10.1056/NEJMoa2002032PubMedGoogle Scholar
World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance, 25 January 2020. Accessed April 14, 2020. https://apps.who.int/iris/handle/10665/330854